tiprankstipranks
Galderma Group AG (CH:GALD)
:GALD
Switzerland Market
GALD
Galderma Group AG
RESEARCH TOOLSreports
Want to see CH:GALD full AI Analyst Report?

Galderma Group AG (GALD) Stock News & Sentiment

14 Followers
Galderma Buy Rating Reiterated as Strong Growth Outlook Drives Higher Revenue Forecasts; $260 Price Target Maintained
Premium
Ratings
Galderma Buy Rating Reiterated as Strong Growth Outlook Drives Higher Revenue Forecasts; $260 Price Target Maintained
8d ago
Galderma: Solid Q1 Outperformance but Limited Upside Keeps Rating at Hold
Premium
Ratings
Galderma: Solid Q1 Outperformance but Limited Upside Keeps Rating at Hold
12d ago
Galderma Group AG: Broad-Based Revenue Outperformance and Lower Execution Risk Support Buy Rating
Premium
Ratings
Galderma Group AG: Broad-Based Revenue Outperformance and Lower Execution Risk Support Buy Rating
12d ago
Capitalizing on Emerging Aesthetic Demand: Galderma’s Menopause and GLP‑1 Weight Loss Opportunity Supports Reiterated Buy Rating
Premium
Ratings
Capitalizing on Emerging Aesthetic Demand: Galderma’s Menopause and GLP‑1 Weight Loss Opportunity Supports Reiterated Buy Rating
25d ago
Galderma Group AG: Buy Rating on Resilient Demand, Growth Catalysts, and Undervalued Long-Term Cash Generation
Premium
Ratings
Galderma Group AG: Buy Rating on Resilient Demand, Growth Catalysts, and Undervalued Long-Term Cash Generation
27d ago
Sustained Growth and Favorable Risk‑Reward in Injectable Aesthetics Underpin Galderma Buy Rating
Premium
Ratings
Sustained Growth and Favorable Risk‑Reward in Injectable Aesthetics Underpin Galderma Buy Rating
1M ago
Galderma: Restylane Contour Label Expansion Strengthens Aesthetics Leadership and Supports Buy Rating
Premium
Ratings
Galderma: Restylane Contour Label Expansion Strengthens Aesthetics Leadership and Supports Buy Rating
1M ago
More CH:GALD News >

GALD News on the Web

Barclays Sticks to Their Buy Rating for Galderma Group AG (GALD)
TipRanks News
Bullish
Galderma Group AG (GALD) Receives a Hold from RBC Capital
TipRanks News
Neutral
UBS Sticks to Its Buy Rating for Galderma Group AG (GALD)
TipRanks News
Bullish
Barclays Keeps Their Buy Rating on Galderma Group AG (GALD)
TipRanks News
Bullish
Capitalizing on Emerging Aesthetic Demand: Galderma’s Menopause and GLP‑1 Weight Loss Opportunity Supports Reiterated Buy Rating
TipRanks News
Bullish
Galderma Group AG (GALD) Gets a Buy from Barclays
TipRanks News
Bullish
Jefferies Reaffirms Their Buy Rating on Galderma Group AG (GALD)
TipRanks News
Bullish
Galderma Group AG: Buy Rating on Resilient Demand, Growth Catalysts, and Undervalued Long-Term Cash Generation
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CH:GALD
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:GALD’s Media Buzz Sentiment?
2 articles about CH:GALD were published this week. In an average week, 3.25 articles are published.
    What is CH:GALD’s weekly average amount of articles?
    In an average week, 3.25 articles about CH:GALD are published.
      What is CH:GALD’s News Sentiment?
      100% of articles about CH:GALD were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week